Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Corbus PharmaceuticalsProvention BioBasilea PharmaceuticaCymaBay TherapeuticsTheratechnologies
SymbolNASDAQ:CRBPNASDAQ:PRVBOTCMKTS:BPMUFNASDAQ:CBAYOTCMKTS:THERF
Price Information
Current Price$6.05$11.90$36.82$6.22$4.16
52 Week RangeBuyBuyBuyBuyHold
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyHold
Consensus Price Target$25.8571$15.3333N/A$13.8889N/A
% Upside from Price Target327.39% upside28.85% upsideN/A123.29% upsideN/A
Trade Information
Market Cap$389.98 million$430.03 million$437.05 million$441.70 million$330.90 million
Beta1.86N/A1.191.260.57
Average Volume613,987411,83125893,24724,270
Sales & Book Value
Annual Revenue$4.82 millionN/A$103.15 million$10 million$45.18 million
Price / Sales80.91N/A4.2442.737.09
CashflowN/AN/AN/AN/A$0.0198 per share
Price / CashN/AN/AN/AN/A209.76
Book Value$0.48 per share$1.76 per share($3.55) per share$2.87 per share$0.47 per share
Price / Book12.60N/A-10.372.178.85
Profitability
Net Income$-55,670,000.00$-26,480,000.00$-19,670,000.00$-72,550,000.00$-4,660,000.00
EPS($0.98)($1.19)N/A($1.26)N/A
Trailing P/E RatioN/AN/A0.00N/A0.00
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-1,219.36%N/AN/AN/A-8.78%
Return on Equity (ROE)-166.99%-82.79%N/A-38.57%-4.84%
Return on Assets (ROA)-100.36%-67.48%N/A-35.62%-1.51%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.17%N/AN/A0.01%1.55%
Current Ratio1.78%17.45%N/A18.66%2.46%
Quick Ratio1.78%17.45%N/A18.66%2.07%
Ownership Information
Institutional Ownership Percentage36.69%1.77%N/A99.53%1.39%
Insider Ownership Percentage8.20%19.60%N/A4.20%N/A
Miscellaneous
Employees77132274332
Shares Outstanding64.46 million37.36 million11.87 million68.69 million76.95 million
Next Earnings Date8/14/2019 (Estimated)8/12/2019 (Estimated)N/A8/8/2019 (Estimated)10/3/2019 (Estimated)
OptionableOptionableNot OptionableNot OptionableOptionableNot Optionable
 Corbus PharmaceuticalsProvention BioBasilea PharmaceuticaCymaBay TherapeuticsTheratechnologies

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel